The European Patent Office (EPO) has published a new patent application, EP4552623A1, for a shunt device designed for glaucoma patients experiencing fibrous encapsulation. The applicant is the Seoul National University R & DB Foundation. This publication signifies the formal disclosure of the invention and its potential for commercialization.

This is a patent publication, not a regulatory rule or guidance. While it pertains to a medical device, it does not impose any new compliance obligations on manufacturers or healthcare providers. Companies operating in the medical device sector, particularly those involved in ophthalmology, may wish to note this patent for competitive intelligence and potential licensing opportunities.